Deutsche Bank AG Raises Stock Position in Tilray Inc (NASDAQ:TLRY)

Deutsche Bank AG lifted its stake in shares of Tilray Inc (NASDAQ:TLRY) by 62.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 75,840 shares of the company’s stock after buying an additional 29,054 shares during the quarter. Deutsche Bank AG’s holdings in Tilray were worth $101,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TLRY. Quinn Opportunity Partners LLC boosted its holdings in Tilray by 108.0% in the fourth quarter. Quinn Opportunity Partners LLC now owns 1,618,080 shares of the company’s stock valued at $2,152,000 after purchasing an additional 840,000 shares in the last quarter. Virtu Financial LLC purchased a new position in Tilray in the fourth quarter worth $1,029,000. Dimensional Fund Advisors LP raised its position in Tilray by 54.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company’s stock worth $2,890,000 after acquiring an additional 769,569 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Tilray by 112.7% in the fourth quarter. JPMorgan Chase & Co. now owns 919,082 shares of the company’s stock valued at $1,222,000 after purchasing an additional 487,051 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Tilray by 20.1% in the fourth quarter. Geode Capital Management LLC now owns 2,405,911 shares of the company’s stock valued at $3,200,000 after purchasing an additional 403,371 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Price Performance

Shares of NASDAQ TLRY opened at $0.40 on Wednesday. Tilray Inc has a fifty-two week low of $0.37 and a fifty-two week high of $2.15. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The firm has a market cap of $402.60 million, a PE ratio of -1.33 and a beta of 1.95. The business has a 50 day moving average price of $0.48 and a two-hundred day moving average price of $0.87.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. Sell-side analysts expect that Tilray Inc will post -0.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on TLRY shares. Piper Sandler dropped their price objective on Tilray from $2.00 to $1.00 and set a “neutral” rating for the company in a research report on Wednesday, April 9th. Roth Capital reaffirmed a “neutral” rating on shares of Tilray in a research note on Monday, April 14th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.